Reference:
1. Choi N, Shin S, Song SU, Sung JH. Minoxidil Promotes Hair Growth through Stimulation of Growth Factor Release from Adipose-Derived Stem Cells. Int J Mol Sci. 2018 Feb 28;19(3):691.
2. Seedat YK, Rawat R. Minoxidil in combination with a beta-adrenergic blocker and a diuretic as an antihypertensive in patients refractory to available medications. S Afr Med J. 1981 May 9;59(20):707-9.
3. Chrysant SG, Chrysant C, Sadeghi M, Berlin L. Cardiac changes from beta-blocker, diuretic and minoxidil combination in hypertension. Cardiology. 1991;78(1):45-52.
4. Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol. 2021 Mar;84(3):737-746.
5. Sánchez-Díaz M, López-Delgado D, Montero-Vílchez T, Salvador-Rodríguez L, Molina-Leyva A, Tercedor-Sánchez J, et al. Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects. J Clin Med. 2021 Sep 20;10(18):4257.
6. Minoxidil. Merative Micromedex® [internet]. 2023 [cited 04/09/2023]. Available from: https://www.micromedexsolutions.com/home/dispatch
7. Nebivolol. Merative Micromedex® [internet]. 2023 [cited 04/09/2023]. Available from: https://www.micromedexsolutions.com/home/dispatch
8. lercanidipin. Drugbank online [internet]. 2023 [cited 04/09/2023]. Available from: https://go.drugbank.com/drugs/DB005
Keywords:
minoxidil, nebivolol, lercanidipine, drug interaction